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Production of tumor necrosis factor by rat mesangial cells in response
to bacterial lipopolysaccharide. Tumor necrosis factor (TNF) is a
cytokine which is produced by mononuclear phagocytes upon activa-
tion by bacterial lipopolysaccharide (LPS) and various other stimuli. In
immune-mediated glomerulonephritis, infiltration of glomeruli by mono-
cytes-macrophages is associated with production of TNF. The purpose
of the present experiments was to determine whether mesangial cells
could also contribute to glomerular TNF synthesis. TNF activity has
been determined in the culture medium of rat mesangial cells using a
L-929 fibroblast lytic assay. This activity was detectable only when the
cells were exposed to LPS (0. Ito 10 sg/ml) and for periods longer than
one hour. The cytotoxic factor was identified as TNF since: (1) the lytic
activity was completely inhibited by an anti-mouse TNF polyclonal
antibody and was associated with suppression of lipoprotein lipase
activity in adipocytes; (2) its molecular weight (110,000 daltons) corre-
sponded to that observed for murine TNF under non-denaturing con-
ditions; and (3) mRNA encoding TNF was expressed by mesangial cells
two hours after addition of LPS. To assess the mechanisms whereby
TNF production was regulated, the role of prostaglandin E2 (PGE2) was
determined. LPS caused a dose-dependent increase of PGE2 synthesis
by mesangial cells. Treatment by indomethacin promoted a suppression
of PGE2 production together with an increase of TNF synthesis,
indicating that PGE2 acted in a negative feedback manner to regulate
the production of TNF. Addition of PGE2 (0.1 to 300 nM) or 8-bromo
cyclic AMP (0.1 to 100 tiM) induced similar dose-dependent reductions
of TNF synthesis. Thus the inhibitory effect of PGE2 probably required
in part cyclic AMP accumulation. It is concluded that TNF is released
by mesangial cells upon stimulation by LPS, and that its synthesis is
regulated by both POE2 and cyclic AMP. Production of TNF could
participate in the mechanism of endotoxin-induced glomerular injury.
Rat mesangial cells possess macrophage-like characteristics
such as the capacity to secrete a wide variety of biologically
active factors including reactive oxygen metabolites [11, neutral
proteinases [2], eicosanoids [31, platelet activating factor [4],
and cytokines [5, 6]. In immune-mediated glomerulonephritis,
the mechanisms of glomerular injury involve most of these
mediators which are released by mesangial cells andlor invading
bone marrow-derived cells. In these models, the importance of
hydrogen peroxide, proteinases and leukotrienes has been
inferred from the beneficial effects of their specific pharmaco-
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logical inhibitors [7—9], and the role of cytokines has been
suggested by the increase in the renal levels of interleukin I
(IL-l) and tumor necrosis factor (TNF) mRNA [10, 11]. If much
interest has focused on IL-l, only little information on the role
of TNF as a mediator of glomerular injury is presently avail-
able. Current evidence suggests that TNF could play a major
role since it has been shown to affect the surface antigen
expression in vascular endothelial cells, the growth of fibro-
blasts and different functions of both polymorphonuclear leu-
kocytes [121 and mesangial cells [131. Moreover, the cellular
origin of TNF in the glomerulus is still unknown. If infiltrating
macrophages represent a potential source of TNF [11, 14], the
glomerular resident cells themselves could synthesize this cy-
tokine as well. The current studies have been designed to
examine TNF synthesis by rat cultured mesangial cells. In
addition, because prostaglandin E2 (POE2) is the main metab-
olite of the cyclooxygenase pathway in these cells [3], we also
checked the role of PGE2 and of its second messenger, cyclic
adenosine monophosphate (cAMP), as an autoregulating factor
of TNF synthesis. We report here that incubation of cultured
rat mesangial cells with bacterial lipopolysaccharide (LPS)
induces the production of TNF and that POE2 and cAMP act in
a negative feedback manner to regulate the release of this
cytokine.
Methods
Mesangial cell culture
Mesangial cells were cultured from isolated rat glomeruli
according to a method previously described [1]. Briefly, gb-
meruli were prepared from the renal cortices of Sprague-
Dawley rats weighing 100 to 150 g by sieving techniques and
differential centrifugations. The final preparation, which was
resuspended in Dulbecco's phosphate-buffered saline (PBS),
was checked for purity under light microscopy. Glomeruli were
free of Bowman's capsule and virtually no afferent or efferent
arterioles could be detected. After treatment by 300 U/mI of
collagenase (300 U/mg; Sigma Chemical Co., St. Louis, Mis-
souri, USA) during 30 minutes at 37°C, isolated glomeruli were
resuspended in RPMI 1640 medium (Flow Laboratories, Irvine,
UK), buffered with 20 mM N-2-hydroxyethylpiperazine-N'-
2-ethanesulfonic acid (HEPES) to pH 7.4, and supplemented
with 10% decomplemented fetal calf serum, 100 U/mI penicillin,
100 g/ml streptomycin, and 2 mri glutamine. Then, they were
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plated onto plastic Petri dishes (Nunc, Roskilde, Denmark) and
cultured at 37°C in 5% CO2 in air. Under such conditions,
mesangial cells appeared after 7 to 14 days in culture and
reached confluency by day 21. Near confluent cells in primary
culture or after one to two passages were used in these studies.
The lack of contamination of these cells by macrophages was
confirmed as previously reported [1].
Triggering TNF release
The Petri dishes were rinsed with serum-free culture medium,
and the medium was replaced with 2 ml of fresh RPMI-1640
medium containing 1% fetal calf serum and bacterial LPS (from
E. coli 026 B6; Sigma Chemical Co.) together with the drug to
be tested. Cell-free supernates were collected after ito 48 hours
of incubation and stored at —70°C until assayed for either TNF
activity or cAMP and PGE2 concentrations.
Tumor necrosis factor assay
The activity of TNF was determined in the cell culture
medium using a L-929 fibroblast lytic assay as previously
described [15]. Briefly, L-929 cells were grown in 96-well
microplates (3 x l0 cells per well) at 37°C in 100 l medium
consisting of Minimum Essential Medium Eagle (Boehringer,
Mannheim, FRG) supplemented with 1% glutamine, 1% non-
essential amino acids (Flow Laboratories), and 10% decomple-
mented fetal calf serum. They were incubated overnight at 37°C
in an atmosphere of 5% CO2 in air. Serial dilutions of test
samples were made in the above medium containing 1 pg/mt
actinomycin D (Sigma Chemical Co.), and the cell culture
medium was replaced with 100 l volumes of these dilutions in
duplicate. After 18 hours, the medium was discarded and the
remaining viable adherent cells were stained with crystal violet
(0.2% in 2% ethanol) for 10 to 15 minutes as previously
described [15]. Microplates were rinsed with tap water, and 100
s1 of 33% acetic acid were added to each well to solubilize the
stained cells. The absorbance of each well was read at 540 nm
with a Titertek Multiscan (Flow Laboratories). Percentage
cytolysis was calculated from the formula l00(a-b)/a, where b
and a are the mean absorbances of duplicate wells with or
without sample dilution. One TNF unit was defined as the
reciprocal of the dilution which causes 50% cytotoxicity under
the conditions of the present assay. An internal standard of
human recombinant TNF (2 x io units/mg; Genzyme, Boston,
Massachusetts, USA) was included as a control. For neutrali-
zation studies, equal volumes of recombinant TNF or of test
samples were mixed with serial dilutions of normal rabbit
serum, anti-mouse TNF (106 neutralizing units per ml; Gen-
zyme) or anti-human TNF (Dr. J. Wietzerbin, Institut Curie,
Paris, France). Samples were incubated at 37°C for 90 minutes
and then assayed in triplicate for residual cytotoxic activity. In
additional experiments, the activity of TNF was identified using
a 3T3-Ll lipoprotein lipase inhibition assay [16]. 3T3-L1 cells
were plated in 3.5 cm plastic tissue culture dishes and grown to
confluence in Dulbecco modified Eagle's medium supplemented
with 10% fetal calf serum (DME-FCS). After one week, they
were differentiated by incubation for 48 hours in DME-FCS
medium supplemented with 10 ig/ml bovine insulin, 0.5 mM
methylisobutylxanthine and I /LM dexamethasone. The differ-
entiated cells were used after one week of culture in DME-FCS
medium supplemented with 50 ng/ml bovine insulin. At that
time, they were exposed to up to 50 jd of 10-fold concentrated
culture medium of mesangial cells in a final volume of 1 ml.
After 16 hours, the medium was aspirated and replaced by 500
pi of DME-FCS medium containing 10 U/mI heparin. The
heparin-releasable lipoprotein lipase (LPL) activity was mea-
sured after one hour incubation at 37°C according to the method
of Corey and Zilversmit L171, and was expressed as mU/dish.
Sephacryl-200 chromatography
The stored frozen medium of LPS-activated mesangial cells
was thawed and concentrated as well as dialyzed using a
Centricon 10 microconcentrator (Amicon Corp., Danvers, Mas-
sachusetts, USA). One ml of 20-fold concentrated medium was
applied to a 1.6 x 100cm Sephacryl S-200 HR column (Pharmacia
Fine Chemicals, Uppsala, Sweden) that had been calibrated
with known standard molecular weight markers (Bio-Rad,
Richmond, California, USA). The column was equilibrated at
4°C with 0.1 M NaC1, 50 mM Tris/HCI buffer, pH 7.4, and the
sample was eluted at a flow rate of 12 ml/hr. Fractions of 1.8 ml
were collected, sterilized by filtration, and assayed after ¼
dilution for cytotoxic activity on L-929 cells.
Preparation of RNA and Northern analysis
Following incubation with or without LPS (10 g/ml), mesan-
gial cells were exposed to the lysing buffer [10 mii Tris/HCI, pH
7.4, containing 100 mM NaCI, 1 mts EDTA, 1% sodium dodecyl
sulfate (SDS), and 250 tg/ml proteinase K (Sigma Chemical)]
for 45 minutes at 37°C. Total RNA was then extracted by the
phenol-chloroform method [18], precipitated with isopropanol
and, after dissolution in 10 mri Tris/HC1 buffer, pH 7.4,
containing 1 mi EDTA, precipitated again with 3 M LiC1. After
two supplementary precipitations with ethanol, RNA concen-
tration and purity were determined by obtaining the A,60 and
A280 readings.
Agarose gel (0.9%) electrophoresis of total RNA (10 tg/lane)
in the presence of 20% formaldehyde was followed by Northern
blot transfer on Gene Screen Plus membrane (New England
Nuclear, Boston, Massachusetts, USA). After prehybridiza-
tion, the filters were hybridized with a 32P-labeled murine TNF
probe [19], from Dr. W. Fiers, Biogen, Ghent, Belgium.
Determination of PGE2 synthesis by mesangial cells
Radioimmunoassay of PGE, was carried out in the culture
medium of mesangial cells after extraction according to the
technique of Maurin [201. After centrifugation, supernatants
(0.5 ml) were diluted in 2.5 ml of H20, acidified to pH 4.0 with
1 N HCI, and purified through C18 columns (Waters Associates,
Milford, Massachusetts, USA). The columns were rinsed with
10 ml H20 to remove polar substances and PGs were eluted
with 7 ml ethylacetate. Extracts were then evaporated under
nitrogen and the dry residues were resuspended in the radioim-
munoassay buffer. PGE2 was assayed at four increasing dilu-
tions by using 13H1 PGE2 from the Radiochemical Centre
(Amersham, UK) and anti-PGE2 antibody from Institut Pasteur
(Paris). This antibody cross reacts only slightly with other PGs
and could be considered as specific [31.
Deter,nination of cAMP synthesis by ,nesangial cells
Cyclic AMP was extracted by adding 0.2 ml of culture
medium to 0.4 ml of an ice-cold ethanol/formic acid mixture
Baud et a!: Production of TNF by mesangial cells 1113
III I I I I
01369 24 48
Time, hours
Fig. 1. Dose-response and time-course curves of LPS-induced TNF
production by cultured rat mesangial cells. Mesangial cells were
incubated for 14 hours with increasing concentrations of LPS (A) or
they were incubated in the presence of I sg/mI of LPS and supernates
were collected at the times indicated (B). TNF concentration was
estimated using the cytotoxic activity assay on L-929 cells. Means and
SEM of values obtained in three experiments are given.
(85: 15, vol/vol). After 30 minutes at 4°C, extracts were evapo-
rated under nitrogen and the dry residues were resuspended in
the radioimmunoassay buffer. Radioimmunoassay of cAMP
was performed after acetylation of the samples, as previously
described [21].
Results
Production of TNF activity by LPS-activated mesangial ce/is
In the absence of exogenous stimulation, that is, other than
medium and serum factors, rat mesangial cells did not sponta-
neously release TNF activity (Fig. 1A). In contrast, incubation
of these cells with various doses of LPS for 14 hours resulted in
a dose-dependent and saturable production of TNF activity.
This stimulatory effect was maximal at 1 gIml. Higher concen-
trations of LPS produced no further increase in TNF activity.
At these concentrations, TNF amounts reached 300 U per ml of
Amount of serum, p.1/we/I
Fig. 2. Effect of increasing amounts of normal rabbit serum (A) and of
two rabbit antiserums directed against human recombinant TNF (•)
andmouse recombinant TNF (LI), respectively, on the cytotoxicity of
mesangial cell supernates. Mesangial cells were incubated with 1 g/ml
LPS for 14 hours. Then, aliquotes of the incubation medium were
incubated with the serums tested for 90 minutes at 37°C and the residual
cytotoxicity was assayed in triplicate. Means and SEM of values
obtained in three experiments are given.
medium, that is, about 300 U/500,000 cells. This value is close
to that obtained with LPS-treated, immunologically-elicited
murine macrophages [22]. It was verified that LPS by itself,
even at the highest doses used, had no effect on the viability of
L-929 cells. The time course for the production of TNF follow-
ing LPS stimulation of mesangial cells is shown in Figure lB. A
slight TNF activity was detectable after three hours of LPS
stimulation. This was followed by a major peak of activity at
nine hours, whereafter activity started to decline. We also
investigated whether anti-TNF antibodies could block the ac-
tivity of mesangial cell-derived cytotoxic factor. Figure 2 shows
that rabbit anti-human-recombinant TNF polyclonal antibody
significantly reduced L-929 cell killing and that anti-mouse
recombinant TNF polyclonal antibody even completely neutral-
ized it. In contrast, normal rabbit serum that had been added at
the highest dose had no effect on mesangial cell-derived cyto-
toxic activity. Thus, this factor appears to be antigenically
related to TNF. Gel filtration on Sephacryl S-200 HR was used
to determine the molecular weight of the mesangial cell-derived
TNF activity (Fig. 3A). Only one peak of cytotoxic activity was
observed with an apparent molecular weight of 110,000. This
value is close to those reported for the molecular weight of
murine TNF, (>70,000 [16] or about 150,000 [23]) when the
biological activity is recovered under nondenaturing conditions.
Since TNF is known to exhibit cachectin-like activity [12], it
was also important to determine whether the conditioned me-
dium of mesangial cells could inhibit the lipoprotein lipase
activity of adipocytes. Cachectin bioactivity was detectable
only in the conditioned medium of LPS-treated mesangial cells.
Indeed, LPL activity released in the supernatants of 3T3-Ll
cells was 14.88 1.41, 14.07 0.98 and 1.51 0.17 mU/dish
after exposure of these cells to 50 p1 of 10-fold concentrated
control medium, mesangial cell-conditioned medium and LPS-
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$ + + I Effect of prostaglandin concentration on LPS-inducedTNF synthesis
POE2 has been shown to reduce the LPS-stimulated TNF
production by macrophages, whereas inhibition of endogenous
POE2 synthesis by indomethacin enhances this production [221.
Because in cultured rat mesangial cells POE2 is the main
product of the cyclooxygenase pathway [3], the effects of
indomethacin on both POE2 and TNF synthesis by LPS-treated
cells were also assessed. In the absence of cyclooxygenase
inhibitor, LPS stimulated PGE2 synthesis in a dose-dependent
manner but saturation concentrations of LPS were not reached
in the experiments reported (Fig. 4A). PGE2 synthesis was
almost completely blocked when indomethacin (1 jIM) was
added to the cell culture medium together with LPS (Fig. 4A).
Under these conditions, the dose-response curve of TNF pro-
duction was modified. Progressive additional increases were
observed at concentrations of LPS higher than 1 gJml in
contrast to the results obtained in the absence of indomethacin
(Fig. 4B). For example, in the culture medium of cells exposed
to 5 g/ml LPS, the level of TNF reached 771 128 U/mI in the
presence of cyclooxygenase inhibitor, whereas it was only 306
85 U/mI in control cultures (N = 3). To confirm the inhibitory
effect of PGE2 on TNF synthesis, mesangial cells were exposed
to 10 sg/ml LPS and 1 sM indomethacin in the presence of
exogenous POE2 (Fig. 5A). POE2 promoted a reduction of TNF
synthesis in a dose-dependent manner between 1 and 100 flM.
These concentrations are close to those of endogenous POE2
which were observed in the culture medium of cells exposed to
LPS at doses higher than 1 gIml, that is, those which effec-
tively induced a reduction of TNF synthesis (approximately 20
ng/ml, that is, 56.8 nM; Fig. 4).
Fig. 3. A. Ge/filtration on Sephacryl S-200 HR. Conditioned medium
of LPS-activated mesangial cells was concentrated 20-fold and chroma-
tographed on a calibrated 1.6 x 100 cm column. Fractions of 1.8 ml
were assayed after ¼ dilution for cytotoxic activity on L-929 cells. B.
Representative Northern blot analysis of TNF mRNA derived from
cultured rat mesangial cells. Mesangial cells were incubated with or
without 10 g/ml LPS for 2 hours. Total RNA was extracted, blotted
and hybridized with a TNF probe. Ten g of RNA were used in each
sample.
treated mesangial cell-conditioned medium, respectively (mean
sEM; N = 3).
Identification of TNF mRNA in LPS-activated
mesangial cells
Mesangial cells were incubated in the absence or in the
presence of LPS (10 g/ml), and total RNA was extracted after
two hours of incubation. For Northern blot analysis, equal
amounts of RNA (10 sg) were used in each lane of the gel. As
shown in Figure 3B, one strongly hybridizing band and a second
weaker band of higher molecular weight were observed after
cell treatment with LPS. In contrast, hybridization signals were
barely detectable before LPS treatment. These results are
consistent with the previously reported TNF mRNA expression
in LPS-treated murine peritoneal macrophages [241, which is
also characterized by two TNF-hybridizing bands, neither band
being due to cross-hybridization with ribosomal RNA [25].
Effect of cAMP concentration on LPS-induced TNF synthesis
To determine whether the inhibitory effect of PGE2 on TNF
synthesis could be attributed to an increase of cAMP, the role
of exogenous PGE2 on the cAMP content of mesangial cells
exposed to 10 p.g/ml LPS and 1 sM indomethacin was studied.
Only a slight increase in cAMP concentration was observed at
doses of PGE2 ranging between 0.1 and 10 n, whereas doses
above 10 nM were markedly stimulatory (Fig. 5B). The inhibi-
tory effect of cAMP was established by directly adding 8-
bromo-cAMP to LPS-stimulated mesangial cells together with I
/LM indomethain. Figure 6 shows that 8-bromo-cAMP caused a
dose-dependent inhibition of TNF production.
Discussion
TNF plays a central role in a number of inflammatory
processes [reviewed in 12]. This cytokine was found to be a
product of mononuclear phagocytes, lymphocytes [12] and
endothelial cells [261. The observations reported here further
extend the range of TNF sources to rat mesangial cells and
provide evidence for the down-regulation of TNF synthesis by
cAMP.
Mesangial cells produced a TNF-related factor that was
cytotoxic for L-929 cells (Fig. 1). This factor was elicited only
after treatment with LPS, at concentrations ranging between
0.1 and 10 jsg/ml. LPS was chosen because numerous studies
have established that LPS is particularly effective to induce
TNF synthesis, while phagocytic stimuli, including zymosan,
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Fig. 4. Effect of indomethacin on LPS-induced PGE2 (A) and TNF (B) synthesis bycultured rat inesangial cells. For PGE2 synthesis (4
experiments), incubations were carried out during 14 hours with (D) or without () I indomethacin. For TNF synthesis (3 experiments),
incubations were carried out over the same period in the presence of 1 tM indomethacin. Means and SEM are given. Control experiments (without
are inactive [22]. Moreover, glomerular cells are already known
to be a target for gram-negative bacteria toxins and particularly
for Escherichia coli toxin [27]. As shown on Figure lB. the
kinetics of LPS-induced TNF production demonstrated a pro-
gressive rise between three and nine hours, followed by an
evident decay. Why TNF activity decreased at the later period
was not determined, but two possibilities could be considered:
First, degradation of TNF might be achieved in the presence of
mesangial cell proteinases [2] as previously shown with L-929
and FS-4 cells [281. Second, mesangial cells could release an
inhibitory factor directed against TNF activity and similar to
that identified in the urine of febrile patients [29]. Identification
of TNF-like activity generated by LPS-activated mesangial
cells was based on immunological, physical and functional
similarities to recombinant TNF. Similarity in antigenicities of
the mesangial cell-derived factor and TNF was indicated by the
fact that anti-human and anti-mouse TNF polyclonal antibodies
both reduced the cytotoxic activity of this factor (Fig. 2).
Cytotoxicity was blocked only partially by anti-human TNF
antibody, while anti-mouse TNF antibody completely neutral-
ized it. These results indicate that human, mouse and rat TNF
are similar in some of their antigenic epitopes but that a higher
degree of homology exists in the three species between mouse
and rat TNF than between human and rat TNF. Such a species
specificity of anti-human and anti-mouse TNF neutralizing
antibodies has been previously described [30].
Molecular weight determination of the TNF-like activity
released by mesangial cells also revealed similarities with
recombinant TNF. The cytotoxic activity recovered from the
medium of LPS-activated mesangial cells under nondenaturing
conditions exhibited an apparent molecular weight of 110,000
(Fig. 3A). This value is close to that reported for murine TNF
when analyzed under identical conditions [16, 23]. Such a form
of TNF could consist of either aggregates with different proteins
[16] or of noncovalent multimers which are, in fact, much more
active than the monomer [311. The medium of LPS-activated
mesangial cells also suppressed lipoprotein lipase activity in
3T3-L1 cells, thus exhibiting a cachectin activity similar to that
of recombinant human TNF [12]. As such, it confirmed the
capacity of rat mesangial cells to produce TNF-cachectin
activity. Finally, TNF gene was expressed by these cells after
exposure to LPS since their RNA hybridized to a murine TNF
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cDNA probe in Northern blot (Fig. 3B). This probe recognized
two bands as previously described for LPS-treated macro-
phages; in fact, the weaker of these bands could represent a
precursor of the main TNF RNA [32].
After identification of TNF as a mediator released by rat
mesangial cells in response to LPS challenge, the mechanisms
whereby its production was regulated were also determined.
We have demonstrated that both endogenous and exogenous
PGE2 down-regulate TNF production by mesangial cells (Figs.
4 and 5). Indeed, LPS induced the production of TNF as well as
that of PGE2, and treatment of the cells with indomethacin
promoted both inhibition of POE2 synthesis and stimulation of
TNF production. However, indomethacin effect on TNF pro-
duction was significant only for LPS concentrations above I jg/
ml, suggesting that POE2 was a potent regulator at concentra-
tions higher than 20 nglml (56.8 nM). These data explain the
difference in the patterns of LPS dose response curves for TNF
(Fig. 1) and POE2 (Fig. 4A) productions. Activation of mesan-
gial cells by LPS yielded to parallel productions of TNF and
POE2, only when TNF synthesis was determined in the pres-
ence of indomethacin (Fig. 4B). The inhibitory effect of PGE2
was confirmed by the reduction of TNF synthesis in the
presence of exogenous POE2 at doses ranging between 10 and
100 nM. Our observations are in general agreement with those
of other investigators who have reported that POE2 regulates
macrophage-derived TNF gene expression [331. They also
suggest that several mediators, released in the glomerulus
during inflammatory processes, could modulate local TNF
production by enhancing PGE2 production. These mediators
include angiotensin II, platelet activating factor, bradykinin
[341, hydrogen peroxide [35], complement components [36] and
ILl [37]. The physiological mechanisms whereby POE2 reduces
TNF synthesis by mesangial cells are still unknown, but they
probably require cAMP generation since: (1) exogenous POE2
induced an increase of cAMP production by mesangial cells
treated by both LPS and indomethacin (Fig. SB) and (2)
8-bromo-cAMP promoted a dose-dependent reduction of TNF
synthesis under identical conditions (Fig. 6). This suggests that
inflammatory mediators, such as histamine, which stimulate
cAMP accumulation in mesangial cells without modifying pros-
taglandin production [38] could also modulate TNF synthesis.
The physiological role of TNF production by mesangial cells
remains to be determined. Unlike IL-i [5] or platelet-derived
growth factor [6], TNF was not synthesized in the absence of
LPS challenge. Thus, its production cannot be considered as an
autocrine mechanism whereby mesangial cells in culture would
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Fig. 6. Effect of 8 bromo-cyclic AMP on LPS-induced TNF synthesis
by cultured rat mesangial cells. Incubations were carried out for 14
hours with 10 g/m1 LPS and 1 M indomethacin. Means and SEM of
values obtained in 3 experiments are given.
promote their own proliferation. In contrast, mesangial cell-
derived TNF could participate in inflammatory processes
within the glomerulus in several ways. It may first stimulate the
synthesis of POE2, PGF2 and prostacyclin by both resident
glomerular cells [13] and infiltrating macrophages [391. More-
over, because TNF has been shown to increase the cAMP
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